Tandem High Dose Chemotherapy and Autologous Stem Cell Rescue for High Risk Pediatric Brain Tumors

NCT01342237 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Brain Tumors

Interventions

DRUG: HDCT 1(TTC), HDCT2(MEC)

Sponsor

Seoul National University Hospital